Jon Congleton owns 0.60% of Mineralys Therapeutics
528,621 shares as of the September 30, 2026 filing, worth $10.9M at the latest close.
MLYS · $1.8B market capGet an email when Jon Congleton’s stake moves.
Free.
The stake
0.60%
worth $10.9M at the latest close
Stake rank
#1,660
by dollar value of the stake
Last sale
27 days ago
Sep 30, 2026
Last buy
1,070 days ago
Nov 22, 2023 · $25,356
Jon Congleton owns 0.60% of Mineralys Therapeutics, Inc.: 528,621 of 88,406,885 shares, worth about $10.9M at the 2026-10-26 close. The stake has moved from 2.54% in 2023 to 0.60% on 2026-09-30, across 15 sales and 4 purchases that moved it since 2016. The last trade that moved it was a planned sale of $1.9M on 2026-09-30.
How the stake is held
as of the Sep 30, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Sep 30, 2026 · Form 4 ↗
HELD DIRECTLY
528,621
100.0%
THE STAKE
528,621
0.60%
Keep reading
Founders who bought this week →← Jennifer Jarrett owns 0.83% of Damora TherapeuticsStephen H. Kramer owns 0.30% of Bright Horizons Family Solutions →Elon Musk owns 44.68% of Space Exploration Technologies →Elon Musk owns 28.42% of Tesla →All 434 founder-led companies →Get an alert when a founder moves →